- Home
- PCB vs PRQR Comparison
PCB vs PRQR Comparison
Compare PCB & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PCB | PRQR |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.0M | 173.8M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | PCB | PRQR |
|---|---|---|
| Price | $22.56 | $1.63 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $24.50 | $8.14 |
| AVG Volume (30 Days) | 19.8K | ★ 518.8K |
| Earning Date | 01-29-2026 | 03-12-2026 |
| Dividend Yield | ★ 3.92% | N/A |
| EPS Growth | ★ 48.28 | N/A |
| EPS | ★ 2.58 | N/A |
| Revenue | ★ $111,686,000.00 | $18,859,556.00 |
| Revenue This Year | $21.55 | N/A |
| Revenue Next Year | $8.65 | $18.44 |
| P/E Ratio | $8.70 | ★ N/A |
| Revenue Growth | ★ 15.97 | N/A |
| 52 Week Low | $16.00 | $1.07 |
| 52 Week High | $24.04 | $3.10 |
Technical Indicators
Market Signals| Indicator | PCB | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 56.35 | 35.35 |
| Support Level | $21.42 | $1.58 |
| Resistance Level | $22.64 | $1.80 |
| Average True Range (ATR) | 0.67 | 0.10 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 75.08 | 13.95 |
Price Performance
Historical ComparisonAbout PCB PCB Bancorp
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.